¿´Æ¬ÊÓƵ

Elham Rahme

Elham Rahme
Contact Information
Address: 

Centre for Outcomes Research and Evaluation
MUHC - RI
5252 de Maisonneuve West
Montreal, QC, Canada H4A 3S5

Phone: 
Tel: (514) 934-1934 X 44724
Fax: (514) 934- 8293
Email address: 
elham.rahme [at] mcgill.ca
Biography: 

My research program focuses on the evaluation of the safety, effectiveness and economic implications of prescribed medications using large administrative databases and on the development of new biostatistical methods for the design and analyses of such studies. The Quebec health administrative databases are a resource for several of my projects in the pharmacoepidemiology domain. We are assessing the effectiveness and safety of the biologic medications (anti-TNF) in the treatment of rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease and psoriasis; the risk of mental health disorders and suicide in patients with autoimmune diseases; and the use and safety, in terms of risk of major bleeding, of new oral anticoagulants in the prevention of stroke in atrial fibrillation as well as in the secondary prevention of venous thromboembolism. In terms of methodology development, my current research includes the validation of methods used to correct for outcome misclassification including multiple imputation and Bayesian methods.

Areas of expertise: 

Dr Elham Rahme is an Associate Professor in the Department of Medicine and an Associate Member in the Department of Epidemiology and Biostatistics of ¿´Æ¬ÊÓƵ She is also a Medical Scientist in the Division of Clinical Epidemiology of the Research Institute of the ¿´Æ¬ÊÓƵ University Health Centre. She holds a PhD in Biostatistics and has extensive experience in pharmacoepidemiology and pharmacoeconomics research.

Ìý

Group: 
Associate Members
Research areas: 
Biostatistics
Health and Social Policy and Health Services
Pharmacoepidemiology
Areas of interest: 

Keywords:Ìýpharmacoepidemiology • drug utilisation • drug adverse events • tumour necrosis factor inhibitors • anticoagulants • mental disorders

Back to top